2022
DOI: 10.1016/j.compbiomed.2022.105605
|View full text |Cite
|
Sign up to set email alerts
|

iLncDA-LTR: Identification of lncRNA-disease associations by learning to rank

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 55 publications
0
6
0
Order By: Relevance
“…We compare AGLDA with seven advanced methods for predicting disease-associated lncRNAs, including GAIRD, GSMV, MGLDA, GTAN, iLncDA-LTR, VADLP, and CNNLDA GAIRD: The method integrated the homogeneous and heterogeneous information from the lncRNA–-disease–miRNA network and inferred the disease-related lncRNAs by the graph convolution and group convolution. GSMV: The prediction model was constructed based on meta-path and transformer to encode the semantic information from multiple perspectives and the dependencies among the lncRNA, disease, and miRNA nodes. MGLDA: The method sampled subgraphs based on multiple meta-paths, and then, the subgraph topologies were encoded and integrated by the graph convolutional autoencoder and the topology-level attention. GTAN: GTAN encoded the neighbor topology of each lncRNA (disease) node and the pairwise attributes by the graph attention mechanism and convolutional neural network, respectively. iLncDA-LTR: The lncRNA similarities and the disease similarities were calculated by the DOSE package and the Needleman Wunsch alignment method.…”
Section: Experimental Evaluation and Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…We compare AGLDA with seven advanced methods for predicting disease-associated lncRNAs, including GAIRD, GSMV, MGLDA, GTAN, iLncDA-LTR, VADLP, and CNNLDA GAIRD: The method integrated the homogeneous and heterogeneous information from the lncRNA–-disease–miRNA network and inferred the disease-related lncRNAs by the graph convolution and group convolution. GSMV: The prediction model was constructed based on meta-path and transformer to encode the semantic information from multiple perspectives and the dependencies among the lncRNA, disease, and miRNA nodes. MGLDA: The method sampled subgraphs based on multiple meta-paths, and then, the subgraph topologies were encoded and integrated by the graph convolutional autoencoder and the topology-level attention. GTAN: GTAN encoded the neighbor topology of each lncRNA (disease) node and the pairwise attributes by the graph attention mechanism and convolutional neural network, respectively. iLncDA-LTR: The lncRNA similarities and the disease similarities were calculated by the DOSE package and the Needleman Wunsch alignment method.…”
Section: Experimental Evaluation and Analysismentioning
confidence: 99%
“…Performance Comparison. We compare AGLDA with seven advanced methods for predicting disease-associated lncRNAs, including GAIRD, 34 GSMV, 33 MGLDA, 32 GTAN, 31 iLncDA-LTR, 41 VADLP, 30 and CNNLDA. 29 • GAIRD: The method integrated the homogeneous and heterogeneous information from the lncRNA−-disease− miRNA network and inferred the disease-related lncRNAs by the graph convolution and group convolution.…”
mentioning
confidence: 99%
“…Recently, with the vigorous development of computer technology and the emergence of machine learning–based methods, 16 researchers have developed related models to solve different biological problems, 17 , 18 such as predicting noncoding RNA (ncRNA)–protein interactions (NPIs), miRNA-disease association (MDAs), and so on. For instance, Zhou et al.…”
Section: Introductionmentioning
confidence: 99%
“…Long noncoding RNAs (lncRNAs) regulate many significant biological processes (such as immune response and embryonic stem cell pluripotency) by linking to RNA-binding proteins ( Wapinski and Chang (2011) ; Chen and Huang (2017) ; Ping et al (2018) ; Wang et al (2020 )), Wang et al (2021 W. ) ; Peng et al (2020) ). They have been important biomarkers for cancers ( Wu et al (2022a) ; Banerjee et al (2020) ; Zhang S. et al (2021) ; Zhou G. et al (2021) ; Peng et al (2022a) ; Liang et al (2022b) ; Peng et al (2021) ; Zhou L. et al (2021) ). For example, lncRNAs AFAP1-AS1, CCAT1, CYTOR, GAS5, HOTAIR, and PVT1 are molecular regulators of lung caner ( Aftabi et al (2021) ).…”
mentioning
confidence: 99%
“…Many machine learning methods have been proposed to infer new LncRNA-Disease Associations (LDAs). For example, graph convolutional completion with conditional random ( Fan et al (2022) ), heterogeneous graph attention network with meta-paths ( Zhao et al (2022) ), graph convolutional auto-encoders ( Silva and Spinosa (2021) ), multi-view attention graph convolutional network and stacking ensemble ( Liang et al (2022b) ), and learning to rank-based model ( Wu et al (2022a) ) are widely used methods for LDA prediction.…”
mentioning
confidence: 99%